ArticleThe American journal of case reports2026
Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis Presenting as Pyrexia of Unknown Origin With Splenic Masses.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Histoplasma capsulatum is a thermally dimorphic fungus capable of causing progressive disseminated histoplasmosis, particularly in immunocompromised hosts. Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome resulting from uncontrolled immune activation. The coexistence of HLH and disseminated histoplasmosis is uncommon and poses significant diagnostic and therapeutic challenges. CASE REPORT A 72-year-old immunosuppressed woman with rheumatoid arthritis treated with methotrexate, hydroxychloroquine, and adalimumab presented with a 2-month history of intermittent high-grade fevers, weight loss, fatigue, and left upper quadrant pain. Physical examination revealed pallor, lethargy, and splenomegaly. Laboratory evaluation showed pancytopenia, markedly elevated ferritin, hypertriglyceridemia, and hypofibrinogenemia. Imaging demonstrated splenomegaly with splenic masses, hepatic lesions, and pulmonary nodules. Disseminated histoplasmosis was confirmed by positive urine Histoplasma antigen testing, immunodiffusion assays (H and M bands), and tissue biopsy demonstrating intracellular yeast forms consistent with Histoplasma. Bone marrow biopsy revealed hypercellularity with histiocytosis and hemophagocytosis. Elevated soluble interleukin-2 receptor levels and decreased natural killer cell activity supported secondary HLH. The patient was treated with liposomal amphotericin B followed by oral itraconazole, resulting in rapid clinical improvement and normalization of inflammatory markers, with radiographic resolution at 12 months. This case is notable for HLH associated with disseminated histoplasmosis presenting with splenic masses, an uncommon finding that can mimic malignancy or other infectious etiologies. CONCLUSIONS This case underscores the importance of considering HLH in patients with disseminated histoplasmosis presenting with persistent fever, cytopenias, and organomegaly. Early recognition and prompt antifungal therapy are critical for favorable outcomes. Although histoplasmosis can occur in immunocompetent individuals, it more commonly affects immunocompromised hosts, as in this patient, highlighting the need for vigilance in high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.